Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MALG vs Ovide and Permethrin for Head Lice
NCT00244439Phase 3Completed
- Start
- Dec 2005
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of malathion in pediculosis capitis (3 arms). Primary endpoint: Cure of Head Lice at 4 weeks. Started Dec 2005; status: completed.
02
Drugs
malathion
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on NCT00244439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00244439.